⌘K

Login Start Free

Home/Insiders/Bumpus Namandje

BN

SEC Insider//CIK 0002060594

Bumpus Namandje

CIK 00020605941 companySALT LAKE CITY, UT

Transactions

7

Companies

1

Filings

4

CIK

0002060594

Recent Transactions

7 trades

Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-06-18$3.18/sh−3,963→ 127,632 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-06-17+88,424→ 131,595 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2026-06-03$3.54/sh−4,386→ 43,171 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2025-06-18+22,016→ 22,016 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-06-18+11,008→ 47,557 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-03-17+36,549→ 36,549 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Stock Option (Right to Buy)
2025-03-17+73,099→ 73,099 total

Companies

1

RECURSION PHARMACEUTICALS, INC.
Director
$RXRX

Recent Filings

4

Address

C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET

SALT LAKE CITY, UT, 84101

View on SEC.gov